Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial

Jose De La Cerda, Laurence Belkoff,Kevin D. Courtney, Elan Diamond, James D’Olimpio, Curtis Dunshee,Lawrence Gervasi, Michael Goodman, Kriti Mittal,David Morris,Paul Sieber,Ronald Tutrone, Michael Ryan, Yi Zhong, Mike Ufer,Neal Shore

Targeted Oncology（2025）

Cited 0|Views1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined